Mechanism of EBV inducing anti-tumour immunity and its therapeutic use-Reference-Cited by-同舟云学术

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Published:2020-12-23 Issue:7844 Volume:590 Page:157-162
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Choi Il-Kyu^ORCID,Wang Zhe,Ke Qiang,Hong Min,Paul Dereck W.,Fernandes Stacey M.,Hu Zhuting,Stevens Jonathan,Guleria Indira,Kim Hye-Jung,Cantor Harvey,Wucherpfennig Kai W.,Brown Jennifer R.,Ritz Jerome^ORCID,Zhang Baochun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-03075-w.pdf

Reference32 articles.

1. Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14, 135–146 (2014).

2. Blankenstein, T., Coulie, P. G., Gilboa, E. & Jaffee, E. M. The determinants of tumour immunogenicity. Nat. Rev. Cancer 12, 307–313 (2012).

3. Long, H. M. et al. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein–Barr virus-transformed B cells. Blood 114, 807–815 (2009).

4. Iheagwara, U. K. et al. Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance. Cancer Immunol. Res. 2, 263–273 (2014).

5. Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B. & Hislop, A. D. The immunology of Epstein–Barr virus-induced disease. Annu. Rev. Immunol. 33, 787–821 (2015).

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assembly and activation of EBV latent membrane protein 1;Cell;2024-09

2. Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies;Biomarker Research;2024-07-29

3. Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases;International Journal of Molecular Sciences;2024-07-26

4. Editorial: EBV-induced T cell immunity in cancers;Frontiers in Immunology;2024-07-09

5. A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection;Nature Communications;2024-06-21